BioCryst Pharmaceuticals BCRX Stock Issued During Period Value Issued For Services
Stock Issued During Period Value Issued For Services at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueIssuedForServices.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's stock issued during period value issued for services.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's stock issued during period value issued for services?
- BioCryst Pharmaceuticals (BCRX) reported stock issued during period value issued for services of $33K in Q1 2026.
- How has BioCryst Pharmaceuticals's stock issued during period value issued for services changed year-over-year?
- BioCryst Pharmaceuticals's stock issued during period value issued for services increased by 450.0% year-over-year, from $6K to $33K.
- What is the long-term trend for BioCryst Pharmaceuticals's stock issued during period value issued for services?
- Over 3 years (2021 to 2025), BioCryst Pharmaceuticals's stock issued during period value issued for services has grown at a -0.6% compound annual growth rate (CAGR), from $60K to $59K.
- What does stock issued during period value issued for services mean?
- The fair market value of equity instruments issued to third-party consultants or service providers in exchange for professional services. This metric captures non-cash expenses incurred to acquire expertise or support without utilizing immediate cash reserves.